pS6-TGFB2-STREP
(Plasmid
#128503)
-
PurposeExpresses human pro-TGFβ2 (from L21 to S414) in mammalian cells. With N-t STREP(2x) tag.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 128503 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCMV-Sport 6
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 4396
- Total vector size (bp) 5575
-
Modifications to backboneIntroduction between SmaI site and L21 (tgfb2) of Kozak sequence, Igk leader and 2x-Strep tag.
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTGFB2
-
Alt nameTransforming growth factor beta-2 proprotein
-
Alt nameCetermin
-
Alt nameGlioblastoma-derived T-cell suppressor factor
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1182
-
GenBank IDNP_001129071.1
-
Entrez GeneTGFB2 (a.k.a. G-TSF, LDS4, TGF-beta2)
- Promoter CMV
-
Tag
/ Fusion Protein
- STREP (2X) tag (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer GGTGGAGGTTCTGGAGGTGGAAGTGGAGGTAGCGCATGGAGCCATCCACAATTCGAAAAGCTCAGCCTGTCTACCTGC
- 3′ sequencing primer CTTTTCGAATTGTGGATGGCTCCAGTCACCAGTGGAACCTGGAACCCAGAGCAG (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pS6-TGFB2-STREP was a gift from F Xavier Gomis-Ruth (Addgene plasmid # 128503 ; http://n2t.net/addgene:128503 ; RRID:Addgene_128503) -
For your References section:
Recombinant production of human alpha2-macroglobulin variants and interaction studies with recombinant G-related alpha2-macroglobulin binding protein and latent transforming growth factor-beta2. Marino-Puertas L, Del Amo-Maestro L, Taules M, Gomis-Ruth FX, Goulas T. Sci Rep. 2019 Jun 24;9(1):9186. doi: 10.1038/s41598-019-45712-z. 10.1038/s41598-019-45712-z PubMed 31235767